Form 4 for ALKS Alkermes plc.
Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-23 · accession 0001127602-22-006622 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-24 | 2022-02-23 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | S - Sale | $24.76 | -12.0K | 18.0K | -40% | -$296.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-02-23 | S | D | 11,983 | $24.76 | 17,994 | D | — | — | (F2) The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.58 to $25.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |